Feb 18, 2026 8:00 am EST LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary
Jan 21, 2026 8:00 am EST DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE
Jan 20, 2026 8:00 am EST LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29
Dec 18, 2025 9:00 am EST Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
Nov 25, 2025 8:30 am EST LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment
Oct 29, 2025 8:00 am EDT LIXTE Biotechnology Holdings to Present at the Spartan Capital Investor Conference 2025, November 3
Oct 16, 2025 8:00 am EDT LIXTE Biotechnology Holdings Highlights Q4 2025 Priorities, Including Ongoing Advancement of Lead Candidate LB-100, Strategic Oncology Business Development and Acquisition Plans
Sep 10, 2025 4:05 pm EDT LIXTE Biotechnology Holdings Makes $2.6 Million Initial Purchase of Digital Currency to Diversify Treasury and for Potential Acquisitions
Sep 3, 2025 8:00 am EDT LIXTE Biotechnology Holdings Appoints Two New Board Members and New Chief Financial Officer